A large California-based study has shown that patients with heart failure who start taking statins, compared with ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
CV Therapeutics Inc. says the MERLIN TIMI-36 study of ranolazine will proceed to the study close-out phase now that the ...
FDA has accepted ARIXTRA (fondaparinux sodium) Injection for priority review — the anticoagulant supplemental drug ...
FDA and Duke Clinical Research Institute will be working to develop a new generation of tools that enable early ...
Administering a cholesterol-lowering drug prior to heart bypass surgery or surgical repair of a faulty heart valve ...
Drugs traditionally used for the treatment of gastric ulcers could have therapeutic potential in chronic heart ...
Plus, underuse of aspirin after stent is “a travesty” says Mayo doctor
Cardiologists were urged to halt the ...